STEPHEN SCHMALBACH: Open Payments
NPI 1215452503 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$225 in 10 payments from 6 companies in 2025. Trend: 2023 $440 · 2024 $229 · 2025 $225
Food & beverage: $225
| Company | Payments | Amount |
|---|---|---|
| Optinose US, Inc. | 4 | $85 |
| GENZYME CORPORATION | 2 | $42 |
| Novartis Pharmaceuticals Corporation | 1 | $30 |
| Regeneron Healthcare Solutions, Inc. | 1 | $27 |
| GlaxoSmithKline, LLC. | 1 | $25 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $17 |
Products named: Xhance, DUPIXENT, NUCALA, NEFFY.
Industry payments across FL — which companies pay providers there.
